The LeukO 2026 Global Virtual Congress on Leukemias, organized by OncoDaily, will take place online on 3–4 September 2026, bringing together international experts for more than 40 scientific sessions on leukemia diagnosis, treatment, research, and multidisciplinary care.

Led scientifically by Marina Konopleva and Rami Komrokji, the programme will cover molecular genetics, risk stratification, measurable residual disease, artificial intelligence in diagnostics, and current and emerging approaches across AML, ALL, CML, CLL, and rare leukemias.

Additional sessions will address targeted therapies, CAR-T and bispecific antibodies, transplantation, relapse and treatment resistance, supportive care, fertility, survivorship, clinical-trial innovation, and access to advanced treatment in resource-limited settings. The virtual congress is designed for clinicians, researchers, laboratory specialists, nurses, pharmacists, trainees, policymakers, and patient advocates involved in leukemia care.